EW - Edwards Lifesciences Corporation Stock Price, News & Analysis

$108.81 -0.71 (-0.65 %)
(As of 11/24/2017 02:40 AM ET)
Previous Close$109.52
Today's Range$108.26 - $109.61
52-Week Range$81.12 - $121.45
Volume835,900 shs
Average Volume1.63 million shs
Market Capitalization$23.18 billion
P/E Ratio30.34
Dividend YieldN/A
Beta0.46

About Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences Corporation logoEdwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.


Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:EW
CUSIP28176E10

Debt

Debt-to-Equity Ratio0.33%
Current Ratio3.49%
Quick Ratio2.76%

Price-To-Earnings

Trailing P/E Ratio30.34
Forward P/E Ratio29.02
P/E Growth1.96

Sales & Book Value

Annual Sales$2.96 billion
Price / Sales7.77
Cash Flow$3.22 per share
Price / Cash33.83
Book Value$14.94 per share
Price / Book7.28

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPS$3.44
Net Income$569.50 million
Net Margins22.47%
Return on Equity27.22%
Return on Assets15.67%

Miscellaneous

Employees11,100
Outstanding Shares211,620,000

Frequently Asked Questions for Edwards Lifesciences Corporation (NYSE:EW)

What is Edwards Lifesciences Corporation's stock symbol?

Edwards Lifesciences Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "EW."

When did Edwards Lifesciences Corporation's stock split? How did Edwards Lifesciences Corporation's stock split work?

Shares of Edwards Lifesciences Corporation split on the morning of Monday, December 14th 2015. The 2-1 split was announced on Thursday, November 19th 2015. The newly created shares were distributed to shareholders after the closing bell on Friday, December 11th 2015. An investor that had 100 shares of Edwards Lifesciences Corporation stock prior to the split would have 200 shares after the split.

How were Edwards Lifesciences Corporation's earnings last quarter?

Edwards Lifesciences Corporation (NYSE:EW) announced its quarterly earnings data on Tuesday, October, 24th. The medical research company reported $0.84 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.86 by $0.02. The medical research company had revenue of $821.50 million for the quarter, compared to analyst estimates of $833.85 million. Edwards Lifesciences Corporation had a return on equity of 27.22% and a net margin of 22.47%. The firm's revenue for the quarter was up 11.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.68 earnings per share. View Edwards Lifesciences Corporation's Earnings History.

When will Edwards Lifesciences Corporation make its next earnings announcement?

Edwards Lifesciences Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, January, 30th 2018. View Earnings Estimates for Edwards Lifesciences Corporation.

What guidance has Edwards Lifesciences Corporation issued on next quarter's earnings?

Edwards Lifesciences Corporation issued an update on its fourth quarter earnings guidance on Tuesday, October, 24th. The company provided earnings per share guidance of $0.84-0.94 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.91. The company issued revenue guidance of $855-895 million, compared to the consensus revenue estimate of $869.55 million.

Where is Edwards Lifesciences Corporation's stock going? Where will Edwards Lifesciences Corporation's stock price be in 2017?

21 brokers have issued 12-month price objectives for Edwards Lifesciences Corporation's stock. Their forecasts range from $105.00 to $150.00. On average, they anticipate Edwards Lifesciences Corporation's share price to reach $124.95 in the next twelve months. View Analyst Ratings for Edwards Lifesciences Corporation.

What are Wall Street analysts saying about Edwards Lifesciences Corporation stock?

Here are some recent quotes from research analysts about Edwards Lifesciences Corporation stock:

  • 1. According to Zacks Investment Research, "Over the last six months, Edwards Lifesciences has outperformed the broader industry. Edwards Lifesciences’ second-quarter 2017 performance was quite promising . Moreover, the raised guidance for 2017 hints at brighter prospects. In fact, the guidance raise was backed by a strong performance by all of the company’s three product lines.   We believe that the recent FDA approvals for several products including SAPIEN 3 THV for valve-in-valve procedures and INSPIRIS RESILIA aortic valve have been boosting investors’ confidence on the stock. However, higher operating expenses raise concerns. The stock’s valuation is also stretched on huge investments in the launch and promotion of products. Stiff competition, currency headwind and reimbursement issues are other challenges." (9/26/2017)
  • 2. Cowen Inc analysts commented, "After hosting meetings with management last week, attending ACC, and reviewing early 1Q'17 MedMine hospital purchasing data, we remain bullish on Edwards' long term growth prospects. We are optimistic that additional layers of growth will be provided by low risk, asymptomatic and moderate AS indications along with EW's mitral and tricuspid platforms. Reiterate Outperform." (3/28/2017)
  • 3. Evercore ISI analysts commented, "With lowered investor expectations, we believe EW shares are poised for a 'catch-up' trade and offers asymmetric risk-reward at current levels. As a result, we are upgrading shares to a Buy, and raising our PT to $110, which offers ~15% upside from current levels." (3/27/2017)

Who are some of Edwards Lifesciences Corporation's key competitors?

Who are Edwards Lifesciences Corporation's key executives?

Edwards Lifesciences Corporation's management team includes the folowing people:

  • Michael A. Mussallem, Chairman of the Board, Chief Executive Officer (Age 64)
  • Scott B. Ullem, Chief Financial Officer, Corporate Vice President (Age 50)
  • Donald E. Bobo Jr., Corporate Vice President - Heart Valve Therapy (Age 55)
  • Catherine M. Szyman, Corporate Vice President- Critical Care (Age 50)
  • Patrick Bruno Verguet, Corporate Vice President- Europe, Middle East and Africa (Age 59)
  • Huimin Wang M.D., Corporate Vice President- Japan, Asia and Pacific (Age 60)
  • Larry L. Wood, Corporate Vice President - Transcatheter Heart Valve Therapy (Age 51)
  • Bernard J. Zovighian, Corporate Vice President -Surgical Heart Valve Therapy (Age 49)
  • Kieran T. Gallahue, Independent Director (Age 53)
  • Leslie Stone Heisz, Independent Director (Age 56)

Who owns Edwards Lifesciences Corporation stock?

Edwards Lifesciences Corporation's stock is owned by a number of of retail and institutional investors. Top institutional investors include Bank of New York Mellon Corp (2.46%), Ameriprise Financial Inc. (2.00%), Brown Advisory Inc. (1.79%), Wells Fargo & Company MN (1.20%), American Century Companies Inc. (1.05%) and Disciplined Growth Investors Inc. MN (0.99%). Company insiders that own Edwards Lifesciences Corporation stock include Barbara J Mcneil, Bernard J Zovighian, Catherine M Szyman, Donald E Bobo Jr, Donald E Bobo, Jr, Dylan Sidoo, Huimin Wang, John T Cardis, Kieran Gallahue, Larry L Wood, Michael A Mussallem, Nick Demare, Patrick B Verguet, Robert WA Sellers, Schack Wesley W Von and Steven R Loranger. View Institutional Ownership Trends for Edwards Lifesciences Corporation.

Who sold Edwards Lifesciences Corporation stock? Who is selling Edwards Lifesciences Corporation stock?

Edwards Lifesciences Corporation's stock was sold by a variety of institutional investors in the last quarter, including Brown Advisory Inc., Egerton Capital UK LLP, Orbimed Advisors LLC, Ameriprise Financial Inc., State of Wisconsin Investment Board, Bank of New York Mellon Corp, Rockefeller Financial Services Inc. and Montag & Caldwell LLC. Company insiders that have sold Edwards Lifesciences Corporation company stock in the last year include Bernard J Zovighian, Catherine M Szyman, Donald E Bobo, Jr, Huimin Wang, Larry L Wood, Michael A Mussallem, Patrick B Verguet and Schack Wesley W Von. View Insider Buying and Selling for Edwards Lifesciences Corporation.

Who bought Edwards Lifesciences Corporation stock? Who is buying Edwards Lifesciences Corporation stock?

Edwards Lifesciences Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Old Mutual Global Investors UK Ltd., Wells Fargo & Company MN, Ardevora Asset Management LLP, Korea Investment CORP, First Trust Advisors LP, Artisan Partners Limited Partnership and American Century Companies Inc.. Company insiders that have bought Edwards Lifesciences Corporation stock in the last two years include Catherine M Szyman, Dylan Sidoo, Kieran Gallahue, Nick Demare and Steven R Loranger. View Insider Buying and Selling for Edwards Lifesciences Corporation.

How do I buy Edwards Lifesciences Corporation stock?

Shares of Edwards Lifesciences Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Edwards Lifesciences Corporation's stock price today?

One share of Edwards Lifesciences Corporation stock can currently be purchased for approximately $108.81.

How big of a company is Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation has a market capitalization of $23.18 billion and generates $2.96 billion in revenue each year. The medical research company earns $569.50 million in net income (profit) each year or $3.44 on an earnings per share basis. Edwards Lifesciences Corporation employs 11,100 workers across the globe.

How can I contact Edwards Lifesciences Corporation?

Edwards Lifesciences Corporation's mailing address is ONE EDWARDS WAY, IRVINE CA, 92614. The medical research company can be reached via phone at 949-250-2500 or via email at [email protected]


MarketBeat Community Rating for Edwards Lifesciences Corporation (EW)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  805 (Vote Outperform)
Underperform Votes:  573 (Vote Underperform)
Total Votes:  1,378
MarketBeat's community ratings are surveys of what our community members think about Edwards Lifesciences Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Edwards Lifesciences Corporation (NYSE:EW)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 5 Hold Ratings, 15 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.81)
Consensus Price Target: $124.95 (14.83% upside)

Consensus Price Target History for Edwards Lifesciences Corporation (NYSE:EW)

Price Target History for Edwards Lifesciences Corporation (NYSE:EW)

Analysts' Ratings History for Edwards Lifesciences Corporation (NYSE:EW)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/26/2017Deutsche Bank AGLower Price TargetHold$122.00 -> $115.00N/AView Rating Details
10/26/2017Morgan StanleyLower Price TargetOverweight$133.00 -> $120.00N/AView Rating Details
10/25/2017Barclays PLCLower Price TargetEqual Weight$120.00 -> $118.00N/AView Rating Details
10/25/2017SunTrust Banks, Inc.Set Price TargetBuy$124.00N/AView Rating Details
10/25/2017Canaccord GenuityReiterated RatingBuy$155.00 -> $135.00N/AView Rating Details
10/12/2017Cowen IncReiterated RatingBuy$135.00N/AView Rating Details
9/1/2017Royal Bank Of CanadaReiterated RatingBuy$130.00N/AView Rating Details
9/1/2017BMO Capital MarketsReiterated RatingBuy$132.00N/AView Rating Details
8/28/2017William BlairReiterated RatingOutperform -> OutperformLowView Rating Details
7/27/2017Stifel NicolausReiterated RatingBuy -> Buy$118.00 -> $130.00HighView Rating Details
7/27/2017Bank of America CorporationBoost Price TargetPositive -> Buy$140.00 -> $150.00HighView Rating Details
7/27/2017Jefferies Group LLCBoost Price TargetBuy$115.00 -> $132.00HighView Rating Details
5/16/2017Goldman Sachs Group IncInitiated CoverageConviction-Buy$138.00LowView Rating Details
3/27/2017Evercore ISIUpgradeIn-Line -> Outperform$98.50 -> $110.00LowView Rating Details
3/20/2017Northland SecuritiesSet Price TargetBuy$105.00LowView Rating Details
2/8/2017Credit Suisse GroupSet Price TargetBuy$120.00N/AView Rating Details
2/2/2017Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
2/2/2017BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
1/3/2017GuggenheimUpgradeNeutral -> Buy$120.00N/AView Rating Details
12/10/2016JMP SecuritiesReiterated RatingEqual Weight$130.00N/AView Rating Details
12/1/2016J P Morgan Chase & CoSet Price TargetBuy$120.00N/AView Rating Details
9/11/2016Wells Fargo & CoReiterated RatingBuyN/AView Rating Details
7/27/2016Citigroup Inc.Boost Price TargetSell$86.00 -> $94.00N/AView Rating Details
6/21/2016Piper Jaffray CompaniesReiterated RatingOverweight$123.00N/AView Rating Details
3/17/2016NomuraInitiated CoverageBuy$101.00N/AView Rating Details
1/4/2016Sterne Agee CRTBoost Price TargetBuy$90.00 -> $92.00N/AView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for Edwards Lifesciences Corporation (NYSE:EW)

Earnings by Quarter for Edwards Lifesciences Corporation (NYSE:EW)

Earnings History by Quarter for Edwards Lifesciences Corporation (NYSE EW)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/30/2018$0.90N/AView Earnings Details
10/24/2017Q3 2017$0.86$0.84$833.85 million$821.50 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.88$1.08$839.16 million$842.00 millionViewN/AView Earnings Details
4/25/2017Q1 2017$0.82$0.94$776.51 million$883.50 millionViewN/AView Earnings Details
2/1/2017Q416$0.72$0.75$760.85 million$767.70 millionViewN/AView Earnings Details
10/25/2016Q316$0.68$0.68$749.14 million$739.40 millionViewN/AView Earnings Details
7/26/2016Q216$0.70$0.76$724.26 million$759.30 millionViewN/AView Earnings Details
4/26/2016Q116$0.66$0.71$664.53 million$697.30 millionViewN/AView Earnings Details
2/2/2016Q415$0.62$0.63$647.44 million$671.10 millionViewN/AView Earnings Details
10/26/2015Q315$0.98$1.07$598.29 million$615.00 millionViewN/AView Earnings Details
7/28/2015Q215$1.05$1.13$604.97 million$616.80 millionViewN/AView Earnings Details
4/23/2015Q115$1.04$1.12$585.16 million$590.30 millionViewN/AView Earnings Details
2/3/2015Q414$0.95$1.06$610.50 million$618.00 millionViewListenView Earnings Details
10/23/2014Q314$0.72$0.80$546.10 million$607.40 millionViewListenView Earnings Details
7/29/2014Q214$0.77$0.88$545.10 million$547.00 millionViewListenView Earnings Details
4/24/2014Q114$0.69$0.76$523.10 million$522.40 millionViewListenView Earnings Details
2/3/2014Q413$0.82$0.91$533.82 million$536.00 millionViewN/AView Earnings Details
10/28/2013Q313$0.66$0.68$490.96 million$496.00 millionViewN/AView Earnings Details
7/25/2013Q2 2013$0.76$0.82$514.59 million$517.20 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.76$0.72$518.69 million$496.70 millionViewN/AView Earnings Details
2/4/2013Q4 2012$0.77$0.77$499.46 million$510.50 millionViewN/AView Earnings Details
10/19/2012$0.56$0.58ViewN/AView Earnings Details
7/24/2012$0.66$0.67ViewN/AView Earnings Details
2/2/2012$0.59$0.62ViewN/AView Earnings Details
10/19/2011$0.39$0.38ViewN/AView Earnings Details
7/21/2011$0.50$0.49ViewN/AView Earnings Details
4/20/2011$0.42$0.51ViewN/AView Earnings Details
2/2/2011$0.53$0.55ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Edwards Lifesciences Corporation (NYSE:EW)
2017 EPS Consensus Estimate: $3.44
2018 EPS Consensus Estimate: $4.05
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.82$0.85$0.84
Q2 20174$0.87$0.89$0.88
Q3 20174$0.79$0.86$0.84
Q4 20174$0.88$0.91$0.90
Q1 20183$0.99$1.09$1.03
Q2 20183$1.01$1.10$1.06
Q3 20183$0.93$1.00$0.96
Q4 20183$0.97$1.05$1.01
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Edwards Lifesciences Corporation (NYSE:EW)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Edwards Lifesciences Corporation (NYSE EW)

Insider Ownership Percentage: 2.13%
Institutional Ownership Percentage: 82.16%
Insider Trades by Quarter for Edwards Lifesciences Corporation (NYSE:EW)
Institutional Ownership by Quarter for Edwards Lifesciences Corporation (NYSE:EW)

Insider Trades by Quarter for Edwards Lifesciences Corporation (NYSE EW)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/20/2017Michael A. MussallemCEOSell32,900$106.86$3,515,694.00View SEC Filing  
11/15/2017Larry L. WoodVPSell18,960$104.76$1,986,249.60View SEC Filing  
11/9/2017Schack Wesley W VonDirectorSell1,000$104.15$104,150.00View SEC Filing  
10/30/2017Donald E. Bobo, Jr.VPSell5,300$101.12$535,936.00View SEC Filing  
10/30/2017Michael A. MussallemCEOSell32,900$100.93$3,320,597.00View SEC Filing  
10/16/2017Larry L WoodVPSell18,960$108.54$2,057,918.40View SEC Filing  
9/29/2017Donald E. Bobo, Jr.VPSell5,300$108.86$576,958.00View SEC Filing  
9/15/2017Larry L. WoodVPSell18,960$112.58$2,134,516.80View SEC Filing  
9/7/2017Michael A. MussallemCEOSell32,900$112.45$3,699,605.00View SEC Filing  
8/30/2017Larry L. WoodVPSell18,960$111.81$2,119,917.60View SEC Filing  
8/29/2017Donald E. Bobo, Jr.VPSell5,300$112.15$594,395.00View SEC Filing  
8/9/2017Michael A. MussallemCEOSell32,900$115.99$3,816,071.00View SEC Filing  
8/4/2017Donald E. Bobo, Jr.VPSell25,000$116.00$2,900,000.00View SEC Filing  
7/31/2017Catherine M. SzymanVPSell4,681$115.78$541,966.18View SEC Filing  
7/31/2017Michael A. MussallemCEOSell32,900$114.80$3,776,920.00View SEC Filing  
7/28/2017Donald E. Bobo, Jr.VPSell5,300$114.68$607,804.00View SEC Filing  
6/29/2017Donald E. Bobo, Jr.VPSell5,600$117.15$656,040.00View SEC Filing  
6/7/2017Michael A. MussallemCEOSell32,900$118.05$3,883,845.00View SEC Filing  
5/31/2017Patrick B. VerguetVPSell10,000$114.88$1,148,800.00View SEC Filing  
5/19/2017Dylan SidooDirectorBuy25,000$0.11$2,750.00
5/19/2017Patrick B. VerguetVPSell22,631$113.16$2,560,923.96View SEC Filing  
5/15/2017Patrick B. VerguetVPSell11,500$111.64$1,283,860.00View SEC Filing  
5/8/2017Donald E. Bobo, Jr.VPSell19,100$110.34$2,107,494.00View SEC Filing  
5/4/2017Donald E. Bobo, Jr.VPSell34,120$109.98$3,752,517.60View SEC Filing  
5/3/2017Michael A. MussallemCEOSell49,100$109.71$5,386,761.00View SEC Filing  
4/28/2017Michael A. MussallemCEOSell49,100$109.78$5,390,198.00View SEC Filing  
4/27/2017Bernard J. ZovighianVPSell18,050$109.21$1,971,240.50View SEC Filing  
4/5/2017Donald E. Bobo, Jr.VPSell13,720$93.58$1,283,917.60View SEC Filing  
3/30/2017Patrick B. VerguetVPSell24,000$93.90$2,253,600.00View SEC Filing  
3/6/2017Donald E. Bobo, Jr.VPSell13,720$90.01$1,234,937.20View SEC Filing  
2/16/2017Michael A. MussallemCEOSell49,100$89.63$4,400,833.00View SEC Filing  
2/3/2017Kieran GallahueDirectorBuy3,000$90.10$270,300.00View SEC Filing  
1/13/2017Michael A. MussallemCEOSell49,100$97.08$4,766,628.00View SEC Filing  
1/12/2017Donald E. Bobo, Jr.VPSell13,720$97.47$1,337,288.40View SEC Filing  
1/12/2017Dylan SidooDirectorBuy30,000$0.13$3,900.00
1/11/2017Dylan SidooDirectorBuy20,000$0.13$2,600.00
12/19/2016Michael A. MussallemCEOSell49,100$91.96$4,515,236.00View SEC Filing  
12/5/2016Huimin WangVPSell13,650$83.53$1,140,184.50View SEC Filing  
12/1/2016Larry L. WoodVPSell13,258$81.85$1,085,167.30View SEC Filing  
11/30/2016Catherine M. SzymanVPBuy12,870$83.43$1,073,744.10View SEC Filing  
11/29/2016Kieran GallahueDirectorBuy3,000$84.63$253,890.00View SEC Filing  
11/22/2016Michael A. MussallemCEOSell49,100$84.67$4,157,297.00View SEC Filing  
11/7/2016Huimin WangVPSell13,650$91.29$1,246,108.50View SEC Filing  
11/2/2016Donald E. Bobo, Jr.VPSell15,000$90.13$1,351,950.00View SEC Filing  
11/1/2016Larry L. WoodVPSell13,257$93.27$1,236,480.39View SEC Filing  
10/27/2016Michael A. MussallemCEOSell49,100$92.77$4,555,007.00View SEC Filing  
10/5/2016Huimin WangVPSell13,650$120.04$1,638,546.00View SEC Filing  
10/3/2016Larry L. WoodVPSell13,257$119.27$1,581,162.39View SEC Filing  
9/6/2016Huimin WangVPSell13,650$115.72$1,579,578.00View SEC Filing  
9/2/2016Donald E. Bobo, Jr.VPSell18,000$115.78$2,084,040.00View SEC Filing  
8/26/2016Patrick B. VerguetVPSell5,000$114.88$574,400.00View SEC Filing  
8/24/2016Patrick B. VerguetVPSell5,000$116.81$584,050.00View SEC Filing  
8/23/2016Patrick B. VerguetVPSell10,092$117.53$1,186,112.76View SEC Filing  
8/11/2016Michael A. MussallemCEOSell49,100$114.01$5,597,891.00View SEC Filing  
8/10/2016John T. CardisDirectorSell5,000$113.21$566,050.00View SEC Filing  
8/9/2016Patrick B. VerguetVPSell10,000$113.48$1,134,800.00View SEC Filing  
8/5/2016Huimin WangVPSell13,650$113.03$1,542,859.50View SEC Filing  
8/1/2016Larry L. WoodVPSell13,257$114.24$1,514,479.68View SEC Filing  
8/1/2016Schack Wesley W. VonDirectorSell6,000$113.98$683,880.00View SEC Filing  
7/29/2016Robert W.A. SellersVPSell10,000$114.33$1,143,300.00View SEC Filing  
7/28/2016Michael A. MussallemCEOSell49,100$113.31$5,563,521.00View SEC Filing  
7/5/2016Huimin WangVPSell13,650$98.44$1,343,706.00View SEC Filing  
7/1/2016Larry L. WoodVPSell13,257$98.79$1,309,659.03View SEC Filing  
6/8/2016Michael A MussallemCEOSell49,100$102.75$5,045,025.00View SEC Filing  
6/6/2016Huimin WangVPSell13,650$101.34$1,383,291.00View SEC Filing  
6/3/2016Larry L WoodVPSell13,257$101.38$1,343,994.66View SEC Filing  
5/31/2016Donald E Bobo JrVPSell18,000$99.04$1,782,720.00View SEC Filing  
5/24/2016Steven R LorangerDirectorBuy5,000$101.07$505,350.00View SEC Filing  
5/18/2016Patrick B VerguetVPSell13,000$102.75$1,335,750.00View SEC Filing  
5/17/2016Patrick B VerguetVPSell5,000$105.00$525,000.00View SEC Filing  
5/16/2016Patrick B VerguetVPSell3,000$104.62$313,860.00View SEC Filing  
5/5/2016Huimin WangVPSell13,650$103.36$1,410,864.00View SEC Filing  
5/5/2016Michael A MussallemCEOSell59,000$104.12$6,143,080.00View SEC Filing  
5/2/2016Patrick B VerguetVPSell7,000$106.86$748,020.00View SEC Filing  
4/29/2016Michael A MussallemCEOSell59,000$106.13$6,261,670.00View SEC Filing  
4/5/2016Huimin WangVPSell13,650$103.97$1,419,190.50View SEC Filing  
3/17/2016Michael A MussallemCEOSell59,000$84.39$4,979,010.00View SEC Filing  
3/7/2016Huimin WangVPSell13,650$87.17$1,189,870.50View SEC Filing  
2/18/2016Michael A. MussallemCEOSell59,000$86.94$5,129,460.00View SEC Filing  
2/18/2016Patrick B. VerguetVPSell5,000$87.00$435,000.00View SEC Filing  
2/16/2016Patrick B. VerguetVPSell8,000$81.58$652,640.00View SEC Filing  
2/5/2016Huimin WangVPSell13,650$83.46$1,139,229.00View SEC Filing  
2/4/2016Barbara J. McneilDirectorSell4,000$83.29$333,160.00View SEC Filing  
1/21/2016Patrick B. VerguetVPSell8,000$77.00$616,000.00View SEC Filing  
1/6/2016Nick DemareDirectorBuy15,000$0.08$1,200.00
1/5/2016Huimin WangVPSell13,650$78.50$1,071,525.00View SEC Filing  
1/5/2016Michael A. MussallemCEOSell59,000$79.82$4,709,380.00View SEC Filing  
12/17/2015Michael A. MussallemCEOSell59,000$81.85$4,829,150.00View SEC Filing  
12/15/2015Patrick B. VerguetVPSell8,000$80.87$646,960.00View SEC Filing  
12/4/2015Huimin WangVPSell6,880$157.96$1,086,764.80View SEC Filing  
11/27/2015Patrick B. VerguetVPSell7,500$164.50$1,233,750.00View SEC Filing  
11/23/2015Robert W.A. SellersVPSell19,200$157.13$3,016,896.00View SEC Filing  
11/17/2015Patrick B. VerguetVPSell4,000$154.50$618,000.00View SEC Filing  
11/5/2015Huimin WangVPSell6,920$156.01$1,079,589.20View SEC Filing  
11/3/2015Patrick B. VerguetVPSell4,338$158.48$687,486.24View SEC Filing  
10/30/2015Patrick B. VerguetVPSell22,000$155.09$3,411,980.00View SEC Filing  
10/29/2015Michael A MussallemCEOSell29,500$154.59$4,560,405.00View SEC Filing  
10/5/2015Huimin WangVPSell6,920$154.30$1,067,756.00View SEC Filing  
10/2/2015Patrick B. VerguetVPSell4,000$154.00$616,000.00View SEC Filing  
10/1/2015Larry L. WoodVPSell7,680$141.52$1,086,873.60View SEC Filing  
9/21/2015Michael A. MussallemCEOSell29,500$142.49$4,203,455.00View SEC Filing  
9/4/2015Huimin WangVPSell6,920$135.19$935,514.80View SEC Filing  
9/1/2015Larry L. WoodVPSell7,680$137.50$1,056,000.00View SEC Filing  
8/24/2015Michael A. MussallemCEOSell29,500$135.25$3,989,875.00View SEC Filing  
8/13/2015West Petroleum Corp. EastInsiderBuy25,000$0.12$2,875.00
7/6/2015Huimin WangVPSell6,920$143.95$996,134.00View SEC Filing  
7/1/2015Larry L WoodVPSell7,680$143.51$1,102,156.80View SEC Filing  
6/24/2015Michael A MussallemCEOSell29,500$143.71$4,239,445.00View SEC Filing  
6/5/2015Huimin WangVPSell6,920$131.39$909,218.80View SEC Filing  
6/1/2015Larry L WoodVPSell7,680$130.47$1,002,009.60View SEC Filing  
5/29/2015Patrick B VerguetVPSell9,662$131.18$1,267,461.16View SEC Filing  
5/21/2015Barbara J McneilDirectorSell2,000$132.59$265,180.00View SEC Filing  
5/19/2015Robert Marc BustinDirectorSell10,000$0.18$1,750.00
5/1/2015Larry L WoodVPSell7,680$127.12$976,281.60View SEC Filing  
4/30/2015Michael A MussallemCEOSell29,500$128.99$3,805,205.00View SEC Filing  
4/6/2015Huimin WangVPSell6,920$140.24$970,460.80View SEC Filing  
4/1/2015Larry L WoodVPSell7,680$142.06$1,091,020.80View SEC Filing  
3/31/2015Robert Marc BustinDirectorBuy15,000$0.15$2,250.00
3/26/2015Michael A MussallemCEOSell29,500$140.10$4,132,950.00View SEC Filing  
3/2/2015Larry L WoodVPSell7,680$132.62$1,018,521.60View SEC Filing  
2/6/2015Huimin WangVPSell6,920$134.79$932,746.80View SEC Filing  
1/5/2015Huimin WangVPSell6,920$126.60$876,072.00View SEC Filing  
1/5/2015Michael A MussallemCEOSell29,500$128.20$3,781,900.00View SEC Filing  
12/22/2014Michael A MussallemCEOSell29,500$133.01$3,923,795.00View SEC Filing  
11/24/2014Michael A MussallemCEOSell29,500$124.25$3,665,375.00View SEC Filing  
11/13/2014Robert W.A. SellersVPSell3,400$124.27$422,518.00View SEC Filing  
11/10/2014Patrick B VerguetVPSell5,000$123.70$618,500.00View SEC Filing  
11/7/2014Schack Wesley W VonDirectorSell3,655$123.00$449,565.00View SEC Filing  
11/5/2014Huimin WangVPSell5,600$120.26$673,456.00View SEC Filing  
10/28/2014Barbara J McneilDirectorSell1,000$117.94$117,940.00View SEC Filing  
10/28/2014Michael A MussallemCEOSell29,500$117.06$3,453,270.00View SEC Filing  
10/28/2014Patrick B VerguetVPSell15,000$117.33$1,759,950.00View SEC Filing  
10/28/2014West Petroleum Corp. EastInsiderBuy15,000$0.12$1,800.00
10/27/2014Patrick B VerguetVPSell10,000$117.00$1,170,000.00View SEC Filing  
10/27/2014West Petroleum Corp. EastInsiderBuy20,000$0.13$2,600.00
10/24/2014Donald E Bobo JrVPSell30,000$114.25$3,427,500.00View SEC Filing  
10/24/2014West Petroleum Corp. EastInsiderBuy35,000$0.14$4,725.00
10/23/2014West Petroleum Corp. EastInsiderBuy40,000$0.15$5,800.00
10/6/2014Huimin WangVPSell5,600$107.00$599,200.00View SEC Filing  
10/3/2014Donald E Bobo JrVPSell25,000$105.00$2,625,000.00View SEC Filing  
9/29/2014Michael A MussallemCEOSell29,500$102.71$3,029,945.00View SEC Filing  
9/10/2014Donald E Bobo JrVPSell25,000$100.00$2,500,000.00View SEC Filing  
9/5/2014Huimin WangVPSell5,600$98.29$550,424.00View SEC Filing  
8/27/2014Carlyn D SolomonVPSell85,200$97.85$8,336,820.00View SEC Filing  
8/27/2014Michael A MussallemCEOSell29,500$98.14$2,895,130.00View SEC Filing  
8/18/2014John T CardisDirectorSell6,000$97.92$587,520.00View SEC Filing  
8/18/2014Larry L WoodVPSell63,752$97.85$6,238,133.20View SEC Filing  
8/13/2014Patrick B VerguetVPSell7,800$95.50$744,900.00View SEC Filing  
8/5/2014Patrick B VerguetVPSell15,000$94.05$1,410,750.00View SEC Filing  
8/4/2014Patrick B VerguetVPSell5,000$93.00$465,000.00View SEC Filing  
8/1/2014Patrick B VerguetVPSell5,000$92.00$460,000.00View SEC Filing  
7/31/2014Michael A MussallemCEOSell29,500$91.98$2,713,410.00View SEC Filing  
7/31/2014Robert Alexander IngramDirectorSell12,500$90.26$1,128,250.00View SEC Filing  
7/31/2014Robert W.A. SellersVPSell8,850$91.47$809,509.50View SEC Filing  
7/30/2014Donald E Bobo JrVPSell23,270$92.00$2,140,840.00View SEC Filing  
7/7/2014Huimin WangVPSell5,600$87.79$491,624.00View SEC Filing  
6/27/2014Donald E Bobo JrVPSell25,000$87.00$2,175,000.00View SEC Filing  
6/24/2014Michael A MussallemCEOSell29,500$85.38$2,518,710.00View SEC Filing  
6/5/2014Huimin WangVPSell5,600$80.73$452,088.00View SEC Filing  
5/30/2014Barbara J McneilDirectorSell1,200$81.20$97,440.00View SEC Filing  
5/28/2014Michael A MussallemCEOSell29,500$79.33$2,340,235.00View SEC Filing  
4/14/2014Donald Bobo, Jr.VPSell25,000$82.00$2,050,000.00View SEC Filing  
4/10/2014Michael MussallemCEOSell29,500$74.71$2,203,945.00View SEC Filing  
4/7/2014Huimin WangVPSell5,600$74.03$414,568.00View SEC Filing  
3/24/2014Michael BowlinDirectorSell1,093$72.33$79,056.69View SEC Filing  
3/6/2014Robert W.A. SellersVPSell1,650$72.88$120,252.00View SEC Filing  
2/6/2014Michael MussallemCEOSell29,500$66.92$1,974,140.00View SEC Filing  
1/27/2014Michael BowlinDirectorSell1,092$68.65$74,965.80View SEC Filing  
1/9/2014Michael MussallemCEOSell29,500$67.04$1,977,680.00View SEC Filing  
1/6/2014Huimin WangVPSell5,600$67.14$375,984.00View SEC Filing  
12/11/2013Patrick VerguetVPSell10,000$62.34$623,400.00View SEC Filing  
12/5/2013Huimin WangVPSell4,650$64.65$300,622.50View SEC Filing  
12/4/2013Michael MussallemCEOSell29,500$64.90$1,914,550.00View SEC Filing  
10/9/2013Michael MussallemCEOSell29,500$72.63$2,142,585.00View SEC Filing  
10/4/2013Huimin WangVPSell4,850$72.19$350,121.50View SEC Filing  
9/12/2013Michael MussallemCEOSell29,500$71.82$2,118,690.00View SEC Filing  
9/5/2013Huimin WangVPSell4,850$71.24$345,514.00View SEC Filing  
8/8/2013Michael MussallemCEOSell29,500$72.28$2,132,260.00View SEC Filing  
8/5/2013Huimin WangVPSell4,850$72.30$350,655.00View SEC Filing  
8/1/2013Patrick VerguetVPSell20,000$73.15$1,463,000.00View SEC Filing  
7/10/2013Michael A MussallemCEOSell29,500$65.60$1,935,200.00View SEC Filing  
7/5/2013Huimin WangVPSell4,850$65.69$318,596.50View SEC Filing  
6/6/2013Michael A MussallemCEOSell29,500$66.25$1,954,375.00View SEC Filing  
6/5/2013Huimin WangVPSell4,850$65.11$315,783.50View SEC Filing  
5/13/2013Paul C RedmondVPSell5,000$67.35$336,750.00View SEC Filing  
5/8/2013Michael A MussallemCEOSell29,200$64.24$1,875,808.00View SEC Filing  
5/7/2013Thomas M AbateCFOSell15,000$63.75$956,250.00View SEC Filing  
5/3/2013Schack Wesley W VonDirectorBuy1,000$64.00$64,000.00View SEC Filing  
5/1/2013David E I PyottDirectorBuy3,000$62.95$188,850.00View SEC Filing  
5/1/2013John H Kehl JrVPSell12,500$62.72$784,000.00View SEC Filing  
4/26/2013Schack Wesley W VonDirectorBuy2,000$64.95$129,900.00View SEC Filing  
4/10/2013Michael A MussallemCEOSell35,000$83.37$2,917,950.00View SEC Filing  
3/13/2013John H Kehl JrVPSell12,500$87.75$1,096,875.00View SEC Filing  
10/5/2012Huimin WangVPSell6,250$109.88$686,750.00View SEC Filing  
10/4/2012Donald E Bobo JrVPSell11,530$110.14$1,269,914.20View SEC Filing  
8/9/2012Michael A MussallemCEOSell35,000$98.69$3,454,150.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Edwards Lifesciences Corporation (NYSE EW)

Source:
DateHeadline
Edwards Lifesciences Corp. breached its 50 day moving average in a Bullish Manner : EW-US : November 22, 2017Edwards Lifesciences Corp. breached its 50 day moving average in a Bullish Manner : EW-US : November 22, 2017
finance.yahoo.com - November 22 at 7:10 PM
Edwards Lifesciences Corporation (EW) CEO Sells $3,515,694.00 in StockEdwards Lifesciences Corporation (EW) CEO Sells $3,515,694.00 in Stock
www.americanbankingnews.com - November 22 at 4:21 AM
What Should You Know About Edwards Lifesciences Corporation’s (EW) Growth?What Should You Know About Edwards Lifesciences Corporation’s (EW) Growth?
finance.yahoo.com - November 17 at 10:18 PM
Edwards Lifesciences: Analyst Recommendations in NovemberEdwards Lifesciences: Analyst Recommendations in November
finance.yahoo.com - November 17 at 12:20 PM
Edwards Lifesciences: Expected to Report Robust Revenues in 2017Edwards Lifesciences: Expected to Report Robust Revenues in 2017
finance.yahoo.com - November 17 at 12:20 PM
Edwards Lifesciences: Small Rise in Net Profit Margins ExpectedEdwards Lifesciences: Small Rise in Net Profit Margins Expected
finance.yahoo.com - November 17 at 12:20 PM
Larry L. Wood Sells 18,960 Shares of Edwards Lifesciences Corporation (EW) StockLarry L. Wood Sells 18,960 Shares of Edwards Lifesciences Corporation (EW) Stock
www.americanbankingnews.com - November 16 at 7:50 PM
Edwards Lifesciences Corporation (EW) Receives Consensus Rating of "Buy" from AnalystsEdwards Lifesciences Corporation (EW) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - November 16 at 5:06 PM
Edwards Lifesciences Corporation (EW) Director Schack Wesley W. Von Sells 1,000 SharesEdwards Lifesciences Corporation (EW) Director Schack Wesley W. Von Sells 1,000 Shares
www.americanbankingnews.com - November 13 at 7:52 PM
ETFs with exposure to Edwards Lifesciences Corp. : November 13, 2017ETFs with exposure to Edwards Lifesciences Corp. : November 13, 2017
finance.yahoo.com - November 13 at 6:59 PM
Industry Group Rank Metrics Limit Edwards Lifesciences (EW) Ratings Upgrade to HoldIndustry Group Rank Metrics Limit Edwards Lifesciences (EW) Ratings Upgrade to Hold
investorplace.com - November 7 at 4:18 PM
Zacks: Brokerages Expect Edwards Lifesciences Corporation (EW) Will Post Quarterly Sales of $861.05 MillionZacks: Brokerages Expect Edwards Lifesciences Corporation (EW) Will Post Quarterly Sales of $861.05 Million
www.americanbankingnews.com - November 6 at 6:03 AM
$0.90 EPS Expected for Edwards Lifesciences Corporation (EW) This Quarter$0.90 EPS Expected for Edwards Lifesciences Corporation (EW) This Quarter
www.americanbankingnews.com - November 4 at 3:18 AM
ETFs with exposure to Edwards Lifesciences Corp. : November 2, 2017ETFs with exposure to Edwards Lifesciences Corp. : November 2, 2017
finance.yahoo.com - November 2 at 7:41 PM
Cramer's lightning round: I'm a buyer of Edwards Lifesciences despite the negativityCramer's lightning round: I'm a buyer of Edwards Lifesciences despite the negativity
finance.yahoo.com - November 1 at 7:33 PM
Edwards Lifesciences Corp. :EW-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Edwards Lifesciences Corp. :EW-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 1 at 7:33 PM
Edwards SAPIEN 3 Transcatheter Valve Demonstrates Significant Cost Savings Over Surgery In Intermediate Risk PatientsEdwards SAPIEN 3 Transcatheter Valve Demonstrates Significant Cost Savings Over Surgery In Intermediate Risk Patients
finance.yahoo.com - October 31 at 7:41 PM
Cramers lightning round: Im a buyer of Edwards Lifesciences despite the negativityCramer's lightning round: I'm a buyer of Edwards Lifesciences despite the negativity
finance.yahoo.com - October 31 at 7:41 PM
Cramer's lightning round: I'm a buyer of Edwards Lifescie...Cramer's lightning round: I'm a buyer of Edwards Lifescie...
finance.yahoo.com - October 31 at 7:41 PM
Edwards Lifesciences Corporation (EW) VP Sells $535,936.00 in StockEdwards Lifesciences Corporation (EW) VP Sells $535,936.00 in Stock
www.americanbankingnews.com - October 30 at 8:21 PM
Michael A. Mussallem Sells 32,900 Shares of Edwards Lifesciences Corporation (EW) StockMichael A. Mussallem Sells 32,900 Shares of Edwards Lifesciences Corporation (EW) Stock
www.americanbankingnews.com - October 30 at 8:20 PM
RSI Alert: Edwards Lifesciences Now Oversold - NasdaqRSI Alert: Edwards Lifesciences Now Oversold - Nasdaq
www.nasdaq.com - October 27 at 9:22 PM
William Blair Comments on Edwards Lifesciences Corporations Q4 2017 Earnings (EW)William Blair Comments on Edwards Lifesciences Corporation's Q4 2017 Earnings (EW)
www.americanbankingnews.com - October 27 at 12:44 PM
FY2017 EPS Estimates for Edwards Lifesciences Corporation (EW) Decreased by AnalystFY2017 EPS Estimates for Edwards Lifesciences Corporation (EW) Decreased by Analyst
www.americanbankingnews.com - October 27 at 8:50 AM
SunTrust Banks Analysts Lower Earnings Estimates for Edwards Lifesciences Corporation (EW)SunTrust Banks Analysts Lower Earnings Estimates for Edwards Lifesciences Corporation (EW)
www.americanbankingnews.com - October 27 at 8:46 AM
Brokers Set Expectations for Edwards Lifesciences Corporations FY2017 Earnings (EW)Brokers Set Expectations for Edwards Lifesciences Corporation's FY2017 Earnings (EW)
www.americanbankingnews.com - October 27 at 8:46 AM
Edwards Lifesciences Corporation Forecasted to Post Q2 2018 Earnings of $1.06 Per Share (EW)Edwards Lifesciences Corporation Forecasted to Post Q2 2018 Earnings of $1.06 Per Share (EW)
www.americanbankingnews.com - October 26 at 1:46 PM
Jefferies Group Analysts Increase Earnings Estimates for Edwards Lifesciences Corporation (EW)Jefferies Group Analysts Increase Earnings Estimates for Edwards Lifesciences Corporation (EW)
www.americanbankingnews.com - October 26 at 11:44 AM
Leerink Swann Analysts Raise Earnings Estimates for Edwards Lifesciences Corporation (EW)Leerink Swann Analysts Raise Earnings Estimates for Edwards Lifesciences Corporation (EW)
www.americanbankingnews.com - October 26 at 11:44 AM
Edwards Lifesciences Corporation (EW) Expected to Post FY2017 Earnings of $3.74 Per ShareEdwards Lifesciences Corporation (EW) Expected to Post FY2017 Earnings of $3.74 Per Share
www.americanbankingnews.com - October 26 at 9:56 AM
Earnings Reaction History: Edwards Lifesciences Corp., 60.0 ... - NasdaqEarnings Reaction History: Edwards Lifesciences Corp., 60.0 ... - Nasdaq
www.nasdaq.com - October 25 at 8:32 PM
Edwards Lifesciences (EW) Q3 Earnings, Sales Lag, View Intact - NasdaqEdwards Lifesciences (EW) Q3 Earnings, Sales Lag, View Intact - Nasdaq
www.nasdaq.com - October 25 at 8:32 PM
Edwards Lifesciences Corp. (EW) Is Sinking After Q3 Profit Disappoints - NasdaqEdwards Lifesciences Corp. (EW) Is Sinking After Q3 Profit Disappoints - Nasdaq
www.nasdaq.com - October 25 at 8:32 PM
Edited Transcript of EW earnings conference call or presentation 24-Oct-17 9:00pm GMTEdited Transcript of EW earnings conference call or presentation 24-Oct-17 9:00pm GMT
finance.yahoo.com - October 25 at 8:32 PM
Edwards Lifesciences (EW) Q3 Earnings, Sales Lag, View IntactEdwards Lifesciences (EW) Q3 Earnings, Sales Lag, View Intact
finance.yahoo.com - October 25 at 8:32 PM
Edwards Lifesciences Crashes After Heart Valve Sales Miss Lofty ViewsEdwards Lifesciences Crashes After Heart Valve Sales Miss Lofty Views
finance.yahoo.com - October 25 at 8:32 PM
Edwards Lifesciences Corporation (EW) PT Lowered to $118.00Edwards Lifesciences Corporation (EW) PT Lowered to $118.00
www.americanbankingnews.com - October 25 at 7:16 PM
Edwards Lifesciences Corporation (EW) Receives "Buy" Rating from SunTrust Banks, Inc.Edwards Lifesciences Corporation (EW) Receives "Buy" Rating from SunTrust Banks, Inc.
www.americanbankingnews.com - October 25 at 9:17 AM
Edwards third-quarter results short of Street estimates; shares fallEdwards third-quarter results short of Street estimates; shares fall
www.reuters.com - October 25 at 4:23 AM
Edwards Lifesciences Corp. Bottom Line Advances 23% In Q3Edwards Lifesciences Corp. Bottom Line Advances 23% In Q3
www.rttnews.com - October 24 at 11:21 PM
Agree To Purchase Edwards Lifesciences Corp At $75, Earn 3.3% Using OptionsAgree To Purchase Edwards Lifesciences Corp At $75, Earn 3.3% Using Options
www.nasdaq.com - October 24 at 11:21 PM
Edwards Lifesciences Reports Third Quarter ResultsEdwards Lifesciences Reports Third Quarter Results
finance.yahoo.com - October 24 at 11:20 PM
Edwards 3rd-quarter results short of Street estimates; shares fallEdwards 3rd-quarter results short of Street estimates; shares fall
finance.yahoo.com - October 24 at 11:20 PM
Edwards Lifesciences misses Street 3Q forecastsEdwards Lifesciences misses Street 3Q forecasts
finance.yahoo.com - October 24 at 11:20 PM
Edwards results fall short of Street estimates; shares tumbleEdwards results fall short of Street estimates; shares tumble
finance.yahoo.com - October 24 at 11:20 PM
Edwards Topples On Third-Quarter Misses, Soft GuidanceEdwards Topples On Third-Quarter Misses, Soft Guidance
finance.yahoo.com - October 24 at 11:20 PM
Edwards Lifesciences Q3 miss pressures shares, down 7%Edwards Lifesciences Q3 miss pressures shares, down 7%
seekingalpha.com - October 24 at 5:29 PM
Edwards Lifesciences Corporation (EW) Issues  Earnings Results, Misses Expectations By $0.02 EPSEdwards Lifesciences Corporation (EW) Issues Earnings Results, Misses Expectations By $0.02 EPS
www.americanbankingnews.com - October 24 at 5:26 PM
Edwards Lifesciences Corporation (EW) Issues Q4 Earnings GuidanceEdwards Lifesciences Corporation (EW) Issues Q4 Earnings Guidance
www.americanbankingnews.com - October 24 at 5:26 PM
This Week's Spectacular Big Cap Earnings ChartsThis Week's Spectacular Big Cap Earnings Charts
finance.yahoo.com - October 23 at 9:17 PM

Social Media

Financials

Chart

Edwards Lifesciences Corporation (NYSE EW) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.